Filing Details
- Accession Number:
- 0001171843-12-003463
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-09-25 06:01:25
- Reporting Period:
- 2012-09-21
- Filing Date:
- 2012-09-25
- Accepted Time:
- 2012-09-25 06:01:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1318641 | Cleveland Biolabs Inc | CBLI | Services-Commercial Physical & Biological Research (8731) | 200077155 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1315696 | James Antal | C/O Cleveland Biolabs, Inc. 73 High Street Buffalo NY 14203 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.005 Per Share | Acquisiton | 2012-09-21 | 2,316 | $2.60 | 27,258 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2011.
Billionaire Hedge Funds
